서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 12 of 12

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2003-03	Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer Kim, DY; Kim, JH; Lee, SH; Kim, TY; Heo, DS; Bang, YJ; Kim, NK Annals of Oncology, Vol.14 No.3, pp.383-387	DOI
2007-08	Efficient cryopreservative conditions for cultivated limbal and conjunctival epithelial cells Oh, Joo Youn; Kim, Mee Kum; Shin, Kyung Seon; Shin, Mi Sun; Wee, Won Ryang; Lee, Jin Hak; Ko, Seon Mi; Lee, Jae Lim Cornea, Vol.26 No.7, pp.840-846	DOI
2008-03	Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer Lee, Keun Seok; Chung, Hyun Cheol; Im, Seock Ah; Park, Yeon Hee; Kim, Chul Soo; Kim, Sung-Bae; Rha, Sun Young; Lee, Min Young; Ro, Jungsil Breast Cancer Research and Treatment, Vol.108 No.2, pp.241-250	DOI
2008-05	A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker Keam, Bhumsuk; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue Molecular Medicine Reports, Vol.1 No.3, pp.415-422	DOI
2008-10	Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study Rothenberg, M. L.; Cox, J. V.; Butts, C.; Navarro, M.; Bang, Y. -J.; Goel, R.; Gollins, S.; Siu, L. L.; Laguerre, S.; Cunningham, D. Annals of Oncology, Vol.19 No.10, pp.1720-1726	DOI
2009-08	Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma Lee, J. O.; Lee, K. W.; Oh, D. Y.; Kim, J. H.; Im, S. A.; Kim, T. Y.; Bang, Y. J. Annals of Oncology, Vol.20 No.8, pp.1402-1407	DOI
2011-04	Cetuximab plus irinotecan in pretreated metastatic colorectal cancer patients: The ELSIE study Lim, Robert; Sun, Yan; Im, Seock-Ah; Hsieh, Ruey-Kuen; Yau, Tsz Kok; Bonaventura, Anthony; Cheirsilpa, Arkom; Esser, Regina; Mueser, Matthias; Advani, Suresh World Journal of Gastroenterology, Vol.17 No.14, pp.1879-1888	DOI
2012-02	Population Pharmacokinetics of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies Wu, Huali; Ramanathan, Ramesh K.; Zamboni, Beth A.; Strychor, Sandra; Ramalingam, Suresh; Edwards, Robert P.; Friedland, David M.; Stoller, Ronald G.; Belani, Chandra P.; Maruca, Lauren J.; Bang, Yung-Jue; Zamboni, William C. Journal of Clinical Pharmacology, Vol.52 No.2, pp.180-194	DOI
2014-09	Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer Lee, Keun-Wook; Kim, Yu Jung; Lee, Kyung-Hun; Han, Sae-Won; Kim, Tae-Yong; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Choi, In Sil; Kim, Jee Hyun Cancer Chemotherapy and Pharmacology, Vol.74 No.3, pp.447-455	DOI
2016-07	Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial Cortes, Javier; Rugo, Hope S.; Twelves, Chris; Awada, Ahmad; Perez, Edith A.; Im, Seock-Ah; Zhao, Carol; Hoch, Ute; Tomkinson, Denise; Buchanan, James; Tagliaferri, Mary; Hannah, Alison; O'Shaughnessy, Joyce SpringerPlus, Vol.5, p. 1033	DOI
2017-09	The Efficacy of Vitamin C on Postoperative Outcomes after Posterior Lumbar Interbody Fusion: A Randomized, Placebo-Controlled Trial Lee, Gun Woo; Yang, Han Seok; Yeom, Jin S.; Ahn, Myun-Whan Clinics in Orthopedic Surgery, Vol.9 No.3, pp.317-324	view file DOI
2021-01	Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study Tan, Antoinette R.; Im, Seock-Ah; Mattar, Andre; Colomer, Ramon; Stroyakovskii, Daniil; Nowecki, Zbigniew; De laurentiis, Michelino; Pierga, Jean-Yves; Jung, Kyung Hae; Schem, Christian; Hogea, Alexandra; Crnjevic, Tanja Badovinac; Heeson, Sarah; Shivhare, Mahesh; Kirschbrown, Whitney P.; Restuccia, Eleonora; Jackisch, Christian The Lancet Oncology, Vol.22 No.1, pp.85-97	DOI

1